Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.

BACKGROUND African-Americans have twice the risk of non-Hispanic whites for presenting with advanced-stage prostate cancer. To investigate the reasons for this difference, we evaluated the association between race/ethnicity and advanced-stage prostate cancer, adjusting for demographic, socioeconomic, clinical, and pathologic factors. METHODS A population-based cohort of 3173 men diagnosed with prostate cancer between October 1, 1994, and October 31, 1995, was analyzed. Medical record abstracts and self-administered survey questionnaires were used to obtain information regarding race/ethnicity, age, marital status, insurance status, educational level, household income, employment status, comorbidity, urinary function, prostate-specific antigen level, tumor grade, and clinical stage. The odds ratio (OR) for advanced-stage prostate cancer was estimated with weighted logistic regression analysis. All P: values were two-sided. RESULTS Clinically advanced-stage prostate cancers were detected more frequently in African-Americans (12.3%) and Hispanics (10.5%) than in non-Hispanic whites (6.3%). Socioeconomic, clinical, and pathologic factors each accounted for about 15% of the increased relative risk. After adjusting for all covariates, the risk remained statistically significantly increased for African-Americans (OR = 2.26; 95% confidence interval [CI] = 1.43 to 3.58) but not for Hispanics (OR = 1.23; 95% CI = 0.73 to 2.08). CONCLUSION Traditional socioeconomic, clinical, and pathologic factors accounted for the increased relative risk for presenting with advanced-stage prostate cancer in Hispanic but not in African-American men.

[1]  H. D. de Koning,et al.  European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam Pilot studies , 1995, Cancer.

[2]  R. Morton,et al.  Racial differences in adenocarcinoma of the prostate in North American men. , 1994, Urology.

[3]  M. Riggs,et al.  Stage at presentation and survival of white and black patients with prostate carcinoma , 1993, Cancer.

[4]  J. Stanford,et al.  Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. , 1999, Journal of the National Cancer Institute.

[5]  M. Riggs,et al.  Incidence, racial differences, and prognostic significance of prostate carcinomas diagnosed with obstructive symptoms , 1994, Cancer.

[6]  I. Thompson,et al.  Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. , 1995, JAMA.

[7]  I. Powell,et al.  A successful recruitment process of African American men for early detection of prostate cancer , 1995 .

[8]  G. Murphy,et al.  The national cancer data base report on race, age, and region variations in prostate cancer treatment , 1997, Cancer.

[9]  T. Stamey,et al.  Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients. , 1989, The Journal of urology.

[10]  H. Anton-Culver,et al.  Demographic differences in prostate cancer incidence and stage: an examination of population diversity in California. , 1998, American journal of preventive medicine.

[11]  P. Walsh,et al.  Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. , 1993, The Journal of urology.

[12]  M. Roach.  Is race an independent prognostic factor for survival from prostate cancer? , 1998, Journal of the National Medical Association.

[13]  A. Polednak,et al.  Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in connecticut , 1992 .

[14]  R. Hayes,et al.  Dietary factors and risks for prostate cancer among blacks and whites in the United States. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  B. Rimer,et al.  Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening. , 1995, Urology.

[16]  J. Cerhan,et al.  Prostate Cancer Trends 1973-1995, SEER Program National Cancer Institute. , 1999 .

[17]  G. Murphy,et al.  The national cancer data base report on prostate cancer , 1995 .

[18]  D. Gleason,et al.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. , 1974, The Journal of urology.

[19]  D. Johnston,et al.  Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens. , 1998, The Journal of urology.

[20]  G. Murphy,et al.  The national cancer data base report on prostate cancer , 1995, Cancer.

[21]  P. Walsh,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. , 2000, The Journal of urology.

[22]  Polednak Ap.  Stage at diagnosis of prostate cancer in Connecticut by poverty and race. , 1997 .

[23]  C. Iselin,et al.  Treatment options, selection, and satisfaction among african american and white men with prostate carcinoma in north carolina , 1998, Cancer.

[24]  K. Pienta,et al.  Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987. , 1995, Urology.

[25]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[26]  W. Chow,et al.  Rural–urban differences in stage at diagnosis. Possible relationship to cancer screening , 1991, Cancer.

[27]  S. Selvin,et al.  Black-white differences in stage-specific cancer survival: analysis of seven selected sites. , 1991, American journal of epidemiology.

[28]  B. Levin,et al.  American Cancer Society Guidelines for the Early Detection of Cancer , 2002, CA: a cancer journal for clinicians.

[29]  Taylor Murray,et al.  Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.

[30]  G. Swanson,et al.  Increasing incidence of cancer of the prostate. The experience of black and white men in the Detroit metropolitan area. , 1994, Archives of internal medicine.

[31]  F. Mostofi,et al.  Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. , 1995, JAMA.

[32]  K. Pienta,et al.  Risk Factors for Prostate Cancer , 1993, Annals of Internal Medicine.

[33]  C. Bennett,et al.  Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  R. Cooper,et al.  Race and the histologic grade of prostate cancer , 1997, The Prostate.

[35]  J. W. Box,et al.  Surgical control of clinically localized prostate carcinoma is equivalent in African‐American and White males , 1998, Cancer.

[36]  L. Polissar,et al.  Race, socioeconomic status, and other prognostic factors for survival from prostate cancer. , 1985, Journal of the National Cancer Institute.

[37]  J. Horm,et al.  Socioeconomic factors and cancer incidence among blacks and whites. , 1991, Journal of the National Cancer Institute.

[38]  O. Brawley,et al.  Prostate Cancer Incidence and Mortality Rates among White and Black Men , 1997, Epidemiology.

[39]  S. B. Robinson,et al.  Attitudes of African Americans regarding screening for prostate cancer. , 1996, Journal of the National Medical Association.

[40]  J. Montie,et al.  Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area: 1973‐1994 , 1996, Cancer.

[41]  K. Pienta,et al.  A unifying model to explain the increased incidence and higher mortality of prostate cancer in black men. , 1999, Urology.

[42]  S. Ndubuisi,et al.  Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. , 1995, Urology.

[43]  B. Achinstein,et al.  Journal of the National Cancer Institute, Vol. 29, 1962: Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance. , 2009, Nutrition reviews.

[44]  A. Whittemore,et al.  Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. , 1995, Journal of the National Cancer Institute.

[45]  I. Powell.  Keynote address: prostate cancer among African-American men--from the bench to the community. , 1998, Journal of the National Medical Association.

[46]  A. Rademaker,et al.  Re: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. , 1990, The Journal of urology.

[47]  L. Woodard,et al.  Cancer in socioeconomically disadvantaged populations. , 1992, Primary care.

[48]  P. Guinan,et al.  Prostate cancer: the stage disadvantage in the black male. , 1991, Journal of the National Medical Association.

[49]  K. Schwartz,et al.  Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system. , 1995, Urology.

[50]  B Barnwell,et al.  SUDAAN User's Manual, Release 7.5, , 1997 .

[51]  P C Prorok,et al.  Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. , 1994, The Journal of urology.